These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 33259623)

  • 61. Immune boosting functional foods and their mechanisms: A critical evaluation of probiotics and prebiotics.
    Ashaolu TJ
    Biomed Pharmacother; 2020 Oct; 130():110625. PubMed ID: 32795926
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The involvement of gut microbiota in inflammatory bowel disease pathogenesis: potential for therapy.
    Cammarota G; Ianiro G; Cianci R; Bibbò S; Gasbarrini A; Currò D
    Pharmacol Ther; 2015 May; 149():191-212. PubMed ID: 25561343
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Research advances in the relationship between childhood malnutrition and gut microbiota].
    Wang HH; Wen FQ; Wei JR
    Zhongguo Dang Dai Er Ke Za Zhi; 2016 Nov; 18(11):1188-1193. PubMed ID: 27817790
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Classical methods and perspectives for manipulating the human gut microbial ecosystem.
    Jiménez-Avalos JA; Arrevillaga-Boni G; González-López L; García-Carvajal ZY; González-Avila M
    Crit Rev Food Sci Nutr; 2021; 61(2):234-258. PubMed ID: 32114770
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Personalized Diets based on the Gut Microbiome as a Target for Health Maintenance: from Current Evidence to Future Possibilities.
    Song EJ; Shin JH
    J Microbiol Biotechnol; 2022 Dec; 32(12):1497-1505. PubMed ID: 36398438
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Current understanding of microbiota- and dietary-therapies for treating inflammatory bowel disease.
    Eom T; Kim YS; Choi CH; Sadowsky MJ; Unno T
    J Microbiol; 2018 Mar; 56(3):189-198. PubMed ID: 29492876
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Application of Gut Bacterial Profiling Information in Precision Nutrition for Obesity and Weight Loss Management.
    Ramos-Lopez O; Aranaz P; Riezu-Boj JI; Milagro FI
    Lifestyle Genom; 2024; 17(1):22-30. PubMed ID: 38219722
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The Kidney-Gut Axis: Implications for Nutrition Care.
    Rossi M; Johnson DW; Campbell KL
    J Ren Nutr; 2015 Sep; 25(5):399-403. PubMed ID: 25812908
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Modulation of the gut microbiota: a focus on treatments for irritable bowel syndrome.
    Harris LA; Baffy N
    Postgrad Med; 2017 Nov; 129(8):872-888. PubMed ID: 28936910
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The metabolic role of the gut microbiota in health and rheumatic disease: mechanisms and interventions.
    Abdollahi-Roodsaz S; Abramson SB; Scher JU
    Nat Rev Rheumatol; 2016 Aug; 12(8):446-55. PubMed ID: 27256713
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Gut microbiota: novel therapeutic target for nonalcoholic fatty liver disease.
    Suk KT; Kim DJ
    Expert Rev Gastroenterol Hepatol; 2019 Mar; 13(3):193-204. PubMed ID: 30791767
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Contribution of the gut microbiota to the regulation of host metabolism and energy balance: a focus on the gut-liver axis.
    Delzenne NM; Knudsen C; Beaumont M; Rodriguez J; Neyrinck AM; Bindels LB
    Proc Nutr Soc; 2019 Aug; 78(3):319-328. PubMed ID: 30628563
    [TBL] [Abstract][Full Text] [Related]  

  • 73. GUT MICROBIOTA, PREBIOTICS, PROBIOTICS, AND SYNBIOTICS IN GASTROINTESTINAL AND LIVER DISEASES: PROCEEDINGS OF A JOINT MEETING OF THE BRAZILIAN SOCIETY OF HEPATOLOGY (SBH), BRAZILIAN NUCLEUS FOR THE STUDY OF HELICOBACTER PYLORI AND MICROBIOTA (NBEHPM), AND BRAZILIAN FEDERATION OF GASTROENTEROLOGY (FBG).
    Barbuti RC; Schiavon LL; Oliveira CP; Alvares-DA-Silva MR; Sassaki LY; Passos MDCF; Farias AQ; Barros LL; Barreto BP; Albuquerque GBML; Alves AM; Navarro-Rodriguez T; Bittencourt PL
    Arq Gastroenterol; 2020; 57(4):381-398. PubMed ID: 33331485
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The human-microbiome superorganism and its modulation to restore health.
    Salvucci E
    Int J Food Sci Nutr; 2019 Nov; 70(7):781-795. PubMed ID: 30843443
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Understanding probiotics' role in allergic children: the clue of gut microbiota profiling.
    Vernocchi P; Del Chierico F; Fiocchi AG; El Hachem M; Dallapiccola B; Rossi P; Putignani L
    Curr Opin Allergy Clin Immunol; 2015 Oct; 15(5):495-503. PubMed ID: 26258924
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The mutual interplay of gut microbiota, diet and human disease.
    Illiano P; Brambilla R; Parolini C
    FEBS J; 2020 Mar; 287(5):833-855. PubMed ID: 31955527
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Gut Microbiota and Obesity: A Role for Probiotics.
    Abenavoli L; Scarpellini E; Colica C; Boccuto L; Salehi B; Sharifi-Rad J; Aiello V; Romano B; De Lorenzo A; Izzo AA; Capasso R
    Nutrients; 2019 Nov; 11(11):. PubMed ID: 31703257
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The human gut microbiome as source of innovation for health: Which physiological and therapeutic outcomes could we expect?
    Doré J; Multon MC; Béhier JM;
    Therapie; 2017 Feb; 72(1):21-38. PubMed ID: 28131442
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Role of the gut microbiota in human nutrition and metabolism.
    Ramakrishna BS
    J Gastroenterol Hepatol; 2013 Dec; 28 Suppl 4():9-17. PubMed ID: 24251697
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Harnessing the gut microbiota to promote metabolic health.
    Zmora N
    Nutr Rev; 2020 Dec; 78(12 Suppl 2):75-78. PubMed ID: 33259609
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.